MA
Martin Auster Raymond James Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
10
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
90.9%
Neutral
9.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Strong Buy
Initiated
| $40 |
63%
upside
| 1 | +52% |
0
%
| 8 Jan ‘26 2 months ago |
|
|
|
Strong Buy
Initiated
| $38 |
31%
upside
| 1 | +5.5% |
0
%
| 19 Dec ‘25 2 months ago |
|
|
|
Outperform
Reiterated
| $71 |
8%
upside
| 2 | +8.5% |
0
%
| 30 Oct ‘25 4 months ago |
|
|
|
Market Perform
Downgraded
| – | – | 1 | – |
–
| 27 Oct ‘25 4 months ago |
|
|
|
Strong Buy
Maintained
| $108 |
68%
upside
| 1 | -14% |
0
%
| 17 Oct ‘25 4 months ago |
|
|
|
Strong Buy
Initiated
| $271 |
13%
upside
| 1 | +16% |
0
%
| 17 Oct ‘25 4 months ago |
|
|
|
Strong Buy
Upgraded
| $35 |
98%
upside
| 2 | +38% |
0
%
| 25 Aug ‘25 6 months ago |
|
|
|
Outperform
Reiterated
| $424 |
31%
upside
| 2 | +1.6% |
0
%
| 1 Aug ‘25 7 months ago |
|